↓ Skip to main content

Pharmacologic management of pain in patients with Chikungunya: a guideline

Overview of attention for article published in Revista da Sociedade Brasileira de Medicina Tropical, December 2016
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
5 tweeters

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
131 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacologic management of pain in patients with Chikungunya: a guideline
Published in
Revista da Sociedade Brasileira de Medicina Tropical, December 2016
DOI 10.1590/0037-8682-0279-2016
Pubmed ID
Authors

Carlos Alexandre Antunes de Brito, Ana Karla Arraes von Sohsten, Clezio Cordeiro de Sá Leitão, Rita de Cássia Coelho Moraes de Brito, Lilian David De Azevedo Valadares, Caroline Araújo Magnata da Fonte, Zelina Barbosa de Mesquita, Rivaldo Venâncio Cunha, Kleber Luz, Helena Maria Carneiro Leão, Cecília Moraes de Brito, Lívia Carla Vinhal Frutuoso

Abstract

From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Brazil 1 <1%
Unknown 129 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 25 19%
Student > Master 21 16%
Researcher 16 12%
Other 10 8%
Student > Postgraduate 8 6%
Other 25 19%
Unknown 26 20%
Readers by discipline Count As %
Medicine and Dentistry 46 35%
Nursing and Health Professions 14 11%
Biochemistry, Genetics and Molecular Biology 8 6%
Immunology and Microbiology 6 5%
Agricultural and Biological Sciences 5 4%
Other 19 15%
Unknown 33 25%